BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 28043679)

  • 1. Presence of Implantable Cardioverter-Defibrillators and Wait-List Mortality of Patients Supported with Left Ventricular Assist Devices as Bridge to Heart Transplantation.
    Younes A; Al-Kindi SG; Alajaji W; Mackall JA; Oliveira GH
    Int J Cardiol; 2017 Mar; 231():211-215. PubMed ID: 28043679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillator and wait-list outcomes in pediatric patients awaiting heart transplantation.
    El-Assaad I; Al-Kindi SG; Oliveira GH; Boyle GJ; Aziz PF
    Heart Rhythm; 2015 Dec; 12(12):2443-8. PubMed ID: 26247317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Implantable Cardioverter-Defibrillators on Waitlist Mortality Among Patients Awaiting Heart Transplantation: An UNOS/OPTN Analysis.
    Vakil K; Duval S; Cogswell R; Eckman P; Levy WC; Anand I; Dardas T; Adabag S
    JACC Clin Electrophysiol; 2017 Jan; 3(1):33-40. PubMed ID: 29759692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis.
    Clerkin KJ; Topkara VK; Mancini DM; Yuzefpolskaya M; Demmer RT; Dizon JM; Takeda K; Takayama H; Naka Y; Colombo PC; Garan AR
    J Heart Lung Transplant; 2017 Jun; 36(6):633-639. PubMed ID: 28089072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry.
    Gandjbakhch E; Rovani M; Varnous S; Maupain C; Chastre T; Waintraub X; Pousset F; Lebreton G; Duthoit G; Badenco N; Himbert C; Leprince P; Hidden-Lucet F
    Arch Cardiovasc Dis; 2016; 109(8-9):476-85. PubMed ID: 27344378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices.
    Emani S; Tumin D; Foraker RE; Hayes D; Smith SA
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27862317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes.
    Truby LK; Garan AR; Givens RC; Takeda K; Takayama H; Trinh PN; Yuzefpolskaya M; Farr MA; Naka Y; Colombo PC; Topkara VK
    Circ Heart Fail; 2018 Apr; 11(4):e004586. PubMed ID: 29666073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist device is protective against cardiac transplant delisting for medical unsuitability.
    Cogswell R; Duval S; John R
    Int J Cardiol; 2018 Oct; 268():51-54. PubMed ID: 29803342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution and benefit of device therapy in patients listed for heart transplant.
    Vandenberk B; Hinderks M; Voros G; Garweg C; Vanhaecke J; Willems R
    Europace; 2018 May; 20(5):786-793. PubMed ID: 28340197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of implantable cardioverter-defibrillator in patients awaiting heart transplant in the continuous-flow left ventricular assist device era.
    Trivedi JR; Slaughter MS; Pan Q; Vijaykrishnan R; Gopinathannair R
    Artif Organs; 2021 Aug; 45(8):845-851. PubMed ID: 33529349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing).
    Clerkin KJ; Garan AR; Wayda B; Givens RC; Yuzefpolskaya M; Nakagawa S; Takeda K; Takayama H; Naka Y; Mancini DM; Colombo PC; Topkara VK
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
    Cantero-Pérez EM; Sobrino-Márquez JM; Grande-Trillo A; Lage-Gallé E; Rangel-Sousa D; Esteve-Ruiz IM; Martínez-Martínez A
    Transplant Proc; 2013; 45(10):3659-61. PubMed ID: 24314988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for mortality or delisting of patients from the pediatric heart transplant waiting list.
    Jeewa A; Manlhiot C; Kantor PF; Mital S; McCrindle BW; Dipchand AI
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):462-8. PubMed ID: 24183905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry.
    Clerkin KJ; Topkara VK; Demmer RT; Dizon JM; Yuzefpolskaya M; Fried JA; Mai X; Mancini DM; Takeda K; Takayama H; Naka Y; Colombo PC; Garan AR
    JACC Heart Fail; 2017 Dec; 5(12):916-926. PubMed ID: 29191299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation.
    Sandner SE; Wieselthaler G; Zuckermann A; Taghavi S; Schmidinger H; Pacher R; Ploner M; Laufer G; Wolner E; Grimm M
    Circulation; 2001 Sep; 104(12 Suppl 1):I171-6. PubMed ID: 11568051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
    Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
    Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.